Colgate-Palmolive Elevates Prabha Narasimhan to EVP – Marketing, Asia-Pacific; Announces Manish Anandani as New MD & CEO for India
Colgate-Palmolive India has announced a key leadership transition, elevating Prabha Narasimhan to Executive Vice President – Marketing, Asia-Pacific Division, effective September 27, 2026. Manish Anandani has been appointed as the new Managing Director and Chief Executive Officer for Colgate-Palmolive India, starting September 28, 2026, to lead the company's next phase of growth focusing on premiumisation, digital transformation, and operational efficiencies. Narasimhan, during her four-year tenure, significantly reinforced Colgate-Palmolive India's market leadership in oral care through premium portfolio growth, digital expansion, and consumer-centric innovation.
Colgate-Palmolive India Taps A Kenvue Veteran As CEO
Colgate-Palmolive India has appointed Manish Anandani, a Kenvue executive, as its new CEO, effective September 28th. This leadership change aligns with the company's strategy to focus on premium products and expand its e-commerce presence, aiming to boost revenue per unit and broaden market reach. While premiumization can increase revenue, investors will be watching to see if the shift to online sales impacts operating margins due to potential increases in digital advertising and platform fees.
Essity to Acquire Kenvue's Feminine Care Business in Brazil for $284 Million
Essity has announced an agreement to acquire Kenvue's feminine care business in Brazil for $284 million, including market-leading brands Carefree, Sempre Livre, and o.b. This strategic move aims to strengthen Essity's position in Brazil's large feminine care market, where it already has a significant presence in incontinence products. The acquisition is subject to regulatory approval and is expected to close in the second quarter of 2027.
Kenvue (KVUE) Launches Zyrtec Spray As Its Undervalued Case Faces A Fresh Test
Kenvue (KVUE) recently launched Zyrtec Allergen Shield Spray, a new drug-free nasal mist, following a strong second quarter in 2026 with sales of US$3,955 million and a US$439.14 million share repurchase. Despite a 9.56% share price increase over 90 days, the stock is considered 1.9% undervalued by analysts, trading slightly below the average price target. The company aims for future growth through digital health retail channels and AI, though faces execution risks in e-commerce.
Kenvue (KVUE) Stock Looks Reasonable Despite A 37% Fair Value Gap
Kenvue (KVUE) stock has gained 10.5% year-to-date, yet a Discounted Cash Flow (DCF) model suggests it's undervalued by approximately 37.2%, pointing to an intrinsic value of about $30.47 per share. However, its P/E ratio of 22.2x is above the industry average, indicating a more balanced valuation picture. The upcoming combination with Kimberly Clark and recent earnings performance are key factors influencing its future cash flow and market sentiment.
Tocqueville Asset Management L.P. Makes New $30.30 Million Investment in Kenvue Inc. $KVUE
Tocqueville Asset Management L.P. has made a new investment of $30.30 million in Kenvue Inc. (NYSE:KVUE), acquiring over 1.5 million shares in the second quarter. This move is part of broader institutional interest, with other major firms like Vanguard Group Inc. and BlackRock Inc. also holding significant stakes. Kenvue recently reported quarterly earnings that missed analyst estimates slightly, but increased its quarterly dividend to $0.21 per share.
Wealthfront Advisers LLC Purchases Shares of 397,683 Kenvue Inc. $KVUE
Wealthfront Advisers LLC has acquired a new position of 397,683 shares in Kenvue Inc. (NYSE:KVUE) during the second quarter, valued at approximately $7.6 million. Kenvue, a consumer health company, reported quarterly revenue of $3.96 billion, missing earnings expectations slightly, and maintains a quarterly dividend of $0.21. The stock currently has an average "Hold" rating from analysts with an average price target of $19.27.
Meeder Advisory Services Inc. Makes New $1.17 Million Investment in Kenvue Inc. $KVUE
Meeder Advisory Services Inc. has invested $1.17 million in Kenvue Inc. (NYSE:KVUE) by purchasing 61,369 shares in the second quarter. This new investment comes as several other hedge funds have also adjusted their holdings in Kenvue, with institutional investors owning 97.64% of the company's stock. Kenvue recently announced a quarterly dividend increase and reported its quarterly earnings, slightly missing revenue and EPS estimates.
Edmond DE Rothschild Holding S.A. Takes Position in Kenvue Inc. $KVUE
Edmond DE Rothschild Holding S.A. acquired a new position in Kenvue Inc. (NYSE:KVUE) during the second quarter, purchasing 900,000 shares valued at approximately $17.2 million. Other institutional investors also made significant investments in Kenvue, with a total of 97.64% of the company's stock owned by institutional investors. Kenvue's stock has an average rating of "Hold" from analysts, with a consensus price target of $19.27, and the company recently declared a quarterly dividend of $0.21 per share.
Deutsche Bank AG Makes New Investment in Kenvue Inc. $KVUE
Deutsche Bank AG recently acquired a new position in Kenvue Inc. (NYSE:KVUE), purchasing over 7.9 million shares valued at approximately $151.3 million, making them an institutional owner of 0.41% of the company. Other institutional investors have also adjusted their stakes in Kenvue, with institutions and hedge funds collectively owning 97.64% of the stock. Kenvue reported earnings of $0.31 per share for the last quarter, slightly missing consensus estimates, and recently announced a quarterly dividend of $0.21 per share.
Neutrogena Parent Stock Takes a Hit Amid Hayden Panettiere Backlash
Shares of Kenvue Inc., the parent company of Neutrogena, have seen a modest decline amid calls for a boycott following the death of Hayden Panettiere. Panettiere had previously alleged that Neutrogena ended their decade-long partnership after she publicly discussed her postpartum depression in 2015. Neutrogena has remained silent on the allegations, which have resurfaced after Panettiere's recent death.
Essity to buy Kenvue's feminine care business in Brazil for $284 million
Essity has announced its intention to acquire Kenvue's feminine care business in Brazil for $284 million. This move is part of Essity's strategic expansion in the personal care market, particularly in the Latin American region. Kenvue, a leader in consumer healthcare products, will be divesting this segment of its operations.
K2 Principal Fund L.P. Invests $4.38 Million in Kenvue Inc. $KVUE
K2 Principal Fund L.P. has acquired a new position in Kenvue Inc. (NYSE:KVUE), purchasing 229,093 shares valued at approximately $4.38 million during the second quarter. Other institutional investors have also adjusted their holdings in Kenvue. The company recently announced a quarterly dividend increase and reported earnings that slightly missed analyst estimates.
Mitsubishi UFJ Asset Management Co. Ltd. Takes $96.09 Million Position in Kenvue Inc. $KVUE
Mitsubishi UFJ Asset Management Co. Ltd. recently acquired 5.03 million shares of Kenvue Inc. (NYSE:KVUE) for approximately $96.09 million, establishing a 0.26% stake. Kenvue's recent quarterly earnings slightly missed expectations, reporting $0.31 per share on $3.96 billion in revenue, though revenue grew 3% year-over-year. The company also declared a quarterly dividend of $0.21 per share, leading to a 4.5% annualized yield, while analysts maintain a "Hold" rating with an average price target of $19.27.
Greenland Capital Management LP Takes $3.84 Million Position in Kenvue Inc. $KVUE
Greenland Capital Management LP has acquired a new stake of 201,087 shares in Kenvue Inc., valued at approximately $3.84 million, during the second quarter. Kenvue (NYSE:KVUE) recently reported quarterly earnings that slightly missed analyst expectations, with EPS of $0.31 versus $0.32 expected and revenue of $3.96 billion against $3.97 billion anticipated. Despite the slight miss, the company maintains a quarterly dividend of $0.21, offering an annualized yield of 4.5%, and analysts generally rate the stock as a "Hold" with a consensus price target of $19.27.
73,621 Shares in Kenvue Inc. $KVUE Bought by Commerzbank Aktiengesellschaft FI
Commerzbank Aktiengesellschaft FI recently acquired 73,621 shares of Kenvue Inc. (NYSE:KVUE) during the second quarter, valued at approximately $1.4 million. Kenvue reported adjusted earnings of $0.31 per share, slightly missing analyst estimates, and announced a quarterly dividend of $0.21 per share, yielding about 4.5%. Analysts currently hold a consensus "Hold" rating for Kenvue with an average price target of $19.27.
7,600,073 Shares in Kenvue Inc. $KVUE Bought by Equity Investment Corp
Equity Investment Corp recently acquired a new position of 7,600,073 shares in Kenvue Inc. (NYSE:KVUE), valued at approximately $145.24 million, making it their 10th largest holding. Other institutional investors also adjusted their stakes in Kenvue, which currently has a market capitalization of $36.15 billion and an average analyst rating of "Hold." Kenvue recently increased its quarterly dividend to $0.21 per share.
BlackRock Inc. Purchases Shares of 150,825,694 Kenvue Inc. $KVUE
BlackRock Inc. has acquired a new position in Kenvue Inc. (NYSE:KVUE), purchasing over 150 million shares valued at approximately $2.88 billion during the second quarter. This makes BlackRock Inc. a significant stakeholder, owning about 7.86% of Kenvue. Other institutional investors like Vanguard Group Inc. and State Street Corp also hold substantial stakes in the consumer health company.
Zyrtec debuts Allergen Shield Spray, rewrites allergy treatment
Zyrtec has launched its new Allergen Shield Spray, designed to prevent allergy symptoms before they start, moving away from traditional reactive treatments. This nasal spray creates a barrier against allergens like pollen and pet dander. Zyrtec is partnering with the PGA Tour for promotion and aims to educate both consumers and healthcare professionals about this innovative preventative approach.
Mondelez Appoints Kenvue Alum Banati CFO
Mondelez International has announced the appointment of Rupesh Banati, formerly CFO at Kenvue, as its new Chief Financial Officer, effective January 2027. Banati will report to CEO Dirk Van de Put and will join the company in October 2026 to ensure a smooth transition with current CFO Luca Zaramella, who is retiring. This strategic hire aims to leverage Banati's extensive experience to support Mondelez's financial leadership.
Nuance Investments LLC Buys Shares of 1,448,488 Kenvue Inc. $KVUE
Nuance Investments LLC has acquired 1,448,488 shares of Kenvue Inc. (NYSE:KVUE) in the second quarter, making it their 6th largest holding. Several other institutional investors also established new positions in Kenvue, with institutional investors now owning 97.64% of the company's stock. Kenvue recently reported quarterly earnings, missing analyst estimates, but increased its quarterly dividend.
NINE MASTS CAPITAL Ltd Takes $20.26 Million Position in Kenvue Inc. $KVUE
NINE MASTS CAPITAL Ltd has acquired a new stake of 1,059,993 shares in Kenvue Inc. (NYSE:KVUE) valued at approximately $20.26 million during the second quarter, making it their 7th largest holding. Other institutional investors like Mirae Asset Global Investments Co. Ltd., Calamos Advisors LLC, and Nomura Asset Management Co. Ltd. also increased their positions in Kenvue. The company recently declared a quarterly dividend of $0.21 per share and reported quarterly earnings of $0.31 per share, slightly missing analyst estimates, with revenue of $3.96 billion.
Should Kenvue’s (KVUE) Stronger Q2 2026 Earnings Shift Investors’ View of Its Profitability Story?
Kenvue Inc. (KVUE) reported stronger Q2 2026 earnings with increased sales and net income, signaling improved profitability. This performance supports the company's focus on simplifying operations and leveraging its health brands, especially with a pending merger with Kimberly Clark. Despite positive earnings, investors should be aware of execution risks in streamlining its complex portfolio and consider diverging fair value estimates among analysts.
Plato Investment Management Ltd Invests $1.30 Million in Kenvue Inc. $KVUE
Plato Investment Management Ltd recently purchased 68,363 shares of Kenvue Inc. (NYSE:KVUE) worth approximately $1.30 million. This investment comes as several other hedge funds have adjusted their stakes in Kenvue, and analysts have issued various ratings for the company, with a current consensus of "Hold" and a price target of $19.27. Kenvue also announced an increased quarterly dividend.
Edgewell's Rob Master on Keeping People at the Center of AI-Powered Marketing
Rob Master, CMO at Edgewell Personal Care, discussed the importance of keeping people at the center of AI-powered marketing in a "Brave Commerce" podcast episode. He emphasized that while technology evolves rapidly, understanding the audience, curiosity, emotional intelligence, and adaptability remain crucial for marketers. Master also highlighted how Edgewell approaches growth for both established and new brands.
Kenvue Shares Drop 2.1% While Deal Calculations Account for 88% of Decline in Tylenol Maker
Kenvue Inc. (NYSE: KVUE) shares dropped 2.14% due mainly to calculations related to its merger with Kimberly-Clark Corporation (NASDAQ: KMB), accounting for 88% of the decline. The value of the cash and stock offer for Kenvue shares is directly influenced by Kimberly-Clark's stock performance. While Tylenol sales, part of Kenvue's Self Care segment, saw increased online searches, there were no new FDA recalls or safety warnings for acetaminophen, which remains safe when used as directed.
B & T Capital Management DBA Alpha Capital Management Makes New Investment in Kenvue Inc. $KVUE
B & T Capital Management DBA Alpha Capital Management has acquired a new stake in Kenvue Inc. (NYSE:KVUE), purchasing 265,605 shares valued at approximately $5.076 million during the second quarter. Other institutional investors, including BlackRock Inc. and Norges Bank, also significantly increased their holdings in Kenvue. Wall Street analysts currently have a consensus "Hold" rating for Kenvue with a target price of $19.27.
Kenvue Inc. stock falls Monday, underperforms market
Kenvue Inc. (KVUE) stock dropped 2.14% on Monday, closing at $18.79. This performance underperformed the broader market, as the S&P 500 Index fell 0.52% and the Dow Jones Industrial Average declined 0.51%. The company's stock is currently 13.98% below its 52-week high of $21.85.
Kenvue’s $1.1 Billion Beauty Segment Faces Scrutiny as Neutrogena Draws Viral Backlash
A viral Neutrogena skincare video has raised questions about brand authenticity for Kenvue, despite receiving over 1.1 million likes. While the controversy has not yet impacted Kenvue's financial performance, its Skin Health & Beauty segment, which includes Neutrogena, saw an 8.4% revenue increase to $1.059 billion in Q1. The company's overall strategy and the pending acquisition by Kimberly-Clark for approximately $48.7 billion are the primary focus for investors.
Should Kenvue’s (KVUE) Stronger Q2 2026 Earnings Shift Investors’ View of Its Profitability Story?
Kenvue (KVUE) reported stronger Q2 2026 earnings with sales rising to US$3,955 million and net income to US$456 million, indicating improved profitability year-over-year. While these results support a near-term positive catalyst, investors should consider the ongoing operational complexity and execution risk, especially concerning the pending merger with Kimberly Clark. The company's narrative projects continued revenue and earnings growth by 2029, suggesting a fair value around its current stock price, though community estimates vary widely.
Should Kenvue’s (KVUE) Stronger Q2 2026 Earnings Shift Investors’ View of Its Profitability Story?
Kenvue Inc. reported stronger Q2 2026 earnings with increased sales and net income, indicating improved profitability compared to the previous year. This performance supports a positive near-term outlook for profitability, though the company still faces execution risks related to simplifying its complex portfolio, especially with a pending merger with Kimberly Clark. Despite these improvements, investor opinions on Kenvue's fair value vary significantly, highlighting ongoing uncertainty.
Wealth Effects LLC Invests $3.38 Million in Kenvue Inc. $KVUE
Wealth Effects LLC has invested $3.38 million in Kenvue Inc. (NYSE:KVUE), acquiring 177,130 shares, which now constitutes 0.9% of its investment portfolio. This investment comes as several other hedge funds have also adjusted their holdings in Kenvue, indicating continued institutional interest in the consumer health company. Kenvue recently reported slightly lower-than-expected quarterly earnings and revenue but announced an increased quarterly dividend.
87,459 Shares in Kenvue Inc. $KVUE Acquired by HBK Sorce Advisory LLC
HBK Sorce Advisory LLC acquired 87,459 shares of Kenvue Inc. (NYSE:KVUE) in the second quarter, valued at approximately $1.72 million. Institutional investors hold 97.64% of Kenvue's stock, with Vanguard and State Street being major shareholders. Kenvue maintains a consensus "Hold" rating from analysts, a $19.27 average price target, and recently declared a $0.21 quarterly dividend, yielding 4.4%.
Kenvue Inc. (NYSE:KVUE) Receives Consensus Rating of "Hold" from Analysts
Analysts have issued a consensus "Hold" rating for Kenvue Inc. (NYSE:KVUE), with an average 12-month price target of $19.27, based on 12 hold and three buy recommendations. The company recently reported quarterly earnings and revenue that slightly missed expectations but still saw a 3% year-over-year revenue increase. Kenvue offers an annualized dividend of $0.84, representing a 4.4% yield, and institutional investors hold a significant majority of its shares.
Alberta Investment Management Corp Acquires New Shares in Kenvue Inc. $KVUE
Alberta Investment Management Corp recently purchased 2,332,279 shares of Kenvue Inc. (NYSE:KVUE) worth approximately $44.57 million during the second quarter, establishing a new stake in the company. Other institutional investors like Vanguard Group Inc., State Street Corp, Geode Capital Management LLC, and Independent Franchise Partners LLP also increased their holdings in Kenvue. The company recently declared an increased quarterly dividend of $0.21 per share and reported Q2 earnings of $0.31 per share on revenue of $3.96 billion, slightly missing analyst estimates.
Kimberly-Clark Appoints Suzana Blades as General Counsel Ahead of Kenvue Acquisition
Kimberly-Clark has appointed Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. This appointment comes as the company prepares for its acquisition of Kenvue. Blades, who has been with Kimberly-Clark for nearly four years, will also join the leadership team post-acquisition, bringing her experience in global litigation and regulatory matters to a strengthened senior leadership team.
The Technical Signals Behind (KVUE) That Institutions Follow
Kenvue Inc. (NASDAQ: KVUE) is showing a neutral sentiment across all time horizons, suggesting a wait-and-see approach for institutional investors. AI models have generated three trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis highlights a 26.2:1 risk-reward short setup, targeting a 7.9% downside with only 0.3% risk.
Kimberly-Clark Elevates Blades to GC Ahead of Kenvue Deal
Kimberly-Clark Corp. has promoted Suzana Blades to senior vice president and general counsel, effective September 1st. This appointment comes as the company prepares to finalize its acquisition of Kenvue Inc. Blades, currently VP and Deputy General Counsel, will join the leadership team, overseeing litigation, government relations, legal operations, and natural solutions.
Kimberly-Clark appoints Suzana Blades as senior vice president and general counsel
Kimberly-Clark has appointed Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. Blades, who has nearly four years of experience at Kimberly-Clark overseeing global litigation and advising on public policy, will join the executive leadership team. Her appointment comes as Kimberly-Clark prepares for its acquisition of Kenvue Inc., aiming to transform into a major health and wellness company.
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel
Kimberly-Clark Corporation has announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. Blades will report to Jeff Melucci, Chief Strategy, Business Development and Administrative Officer, and will also join Kimberly-Clark's Executive Leadership Team. She brings extensive global legal expertise from her previous roles at Kimberly-Clark and ConocoPhillips, and will play a critical role in the company's growth and its pending acquisition of Kenvue Inc.
Kimberly-Clark Names Legal Chief for Pending Kenvue Acquisition
Kimberly-Clark (NASDAQ: KMB) has appointed Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. She will also join Kimberly-Clark's Executive Leadership Team and the leadership team for the pending acquisition of Kenvue (NYSE: KVUE). Blades brings extensive experience in global litigation, government relations, and legal operations from her previous roles at Kimberly-Clark, ConocoPhillips, Hess, and Arnold & Porter.
Kimberly Clark (KMB) Could Be 7% Below Fair Value After 2026 Outlook Cut
Kimberly-Clark (KMB) has reduced its 2026 outlook due to market disruptions in China, softer category trends, and North American shipment volatility. Despite these challenges, the company's strong brand equity and innovation pipeline are expected to drive sustainable EPS growth, leading to a fair value estimate of $117.00, suggesting the stock is currently undervalued by about 7%. The article also highlights long-term growth drivers such as cost efficiencies and sustainable fiber product development.
Kenvue Inc. stock rises Thursday, outperforms market
Shares of Kenvue Inc. (KVUE) rose 1.16% on Thursday to $19.20, outperforming the broader market. The S&P 500 Index and Dow Jones Industrial Average also saw gains. Kenvue Inc. closed 12.55% below its 52-week high.
Kenvue options activity surges on bullish call bets ahead of merger news
Kenvue Inc. (KVUE) is experiencing a surge in bullish call options activity, with over 12,000 contracts traded, indicating traders anticipate a significant upward price movement. The high concentration of calls at the $19.50 strike price, expiring soon, alongside a spike in volatility, suggests market participants are positioning for news related to the pending $40–48.7 billion acquisition by Kimberly-Clark, expected to close in Q4 2026. This aggressive options trading follows recent Q2 earnings that slightly missed estimates, implying a focus on potential merger catalysts rather than past financial performance.
Kenvue options activity surges on bullish call bets ahead of merger news
Kenvue Inc. (KVUE) options activity has surged, primarily driven by bullish call options targeting a $19.50 strike price expiring soon, with a call/put ratio of nearly 20:1. This aggressive options trading, coupled with a spike in implied volatility, suggests that traders anticipate a significant upward price movement, likely fueled by news related to the impending $40–48.7 billion acquisition by Kimberly-Clark, expected to close in Q4 2026. Despite a slight miss on Q2 earnings, market focus appears to be on the merger, with analysts setting an average target of $19.50 and a fair value estimate of $21.65.
Kimberly-Clark Names Suzana Blades General Counsel Ahead of Kenvue Deal
Kimberly-Clark Corporation has appointed Suzana Blades as senior vice president and general counsel, effective September 1, 2026. This promotion comes as the company prepares for its acquisition of Kenvue Inc. and a broader transformation of its health and wellness portfolio, placing Blades at the center of integration and regulatory considerations. Blades, who has been with Kimberly-Clark for nearly four years, previously served as vice president and deputy general counsel for litigation, government relations, legal operations, and Natural Solutions.
Kimberly-Clark appoints Suzana Blades as senior vice president and general counsel
Kimberly-Clark has appointed Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. She will also join the leadership team for Kimberly-Clark's pending acquisition of Kenvue Inc. Blades has been with Kimberly-Clark for nearly four years, previously serving as Vice President & Deputy General Counsel, overseeing global litigation and public policy.
Kimberly-Clark names Suzana Blades as general counsel
Kimberly-Clark Corporation has announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. Blades, who currently serves as Vice President & Deputy General Counsel at Kimberly-Clark, will also join the company’s Executive Leadership Team and the leadership team for the pending Kenvue Inc. acquisition. She brings extensive legal experience from her nearly four years with Kimberly-Clark and previous roles at ConocoPhillips and Hess Corporation.
Kimberly-Clark names Suzana Blades as general counsel By Investing.com
Kimberly-Clark Corporation announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. Blades will report to Jeff Melucci and join the company's Executive Leadership Team, and will also be part of the leadership team following Kimberly-Clark's acquisition of Kenvue Inc. She previously served as Vice President & Deputy General Counsel at Kimberly-Clark and held positions at ConocoPhillips and Hess Corporation.
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel
Kimberly-Clark Corporation has announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. Blades, who has been with Kimberly-Clark for nearly four years, will also join the executive leadership team and report to Jeff Melucci, Chief Strategy, Business Development and Administrative Officer. This appointment comes as the company is undergoing a transformational period, including the pending acquisition of Kenvue Inc.
